Lupin's deal with TTP plc UK isn't just about better inhalers; it’s a desperate play in the high-stakes **pharmaceutical technology** sector.
Forget quantum computing. The real revolution in **materials science** is happening in pliable polymers, and students are leading the charge away from traditional **engineering**.
The hype around BBB-crossing antibody technology masks a brutal reality. Is this truly a breakthrough, or just another pharmaceutical mirage in the fight against neurodegeneration?
Forget the festive facade. This 3D-printed ice structure reveals the true, shallow ambition behind cutting-edge **physics research** funding.